| | | | |

Localized Mesothelioma Successfully Treated with Chemotherapy and Surgery

ByHolly Zink
A patient with a rare, localized form of pleural mesothelioma has been successfully treated and has been disease-free for 12 months.

A patient with a rare, localized malignant pleural mesothelioma has been successfully treated. The patient received chemotherapy and surgery and has been disease-free for 12 months. Many believe that a localized form of pleural mesothelioma might have a better survival outlook. This is compared with patients who have the more common, diffuse variety.

This latest report comes from a Japanese team of thoracic surgeons.

Local vs. Diffuse Mesothelioma

Malignant mesothelioma is a rare cancer affecting an estimated 2,500 Americans annually. All forms of mesothelioma have been linked to asbestos exposure. Malignant pleural mesothelioma is the most common form of malignant mesothelioma.

Most pleural mesothelioma patients have a type of cancer that tends to spread quickly. It spreds across the thin membrane that surrounds the lungs. Patients with localized malignant mesothelioma have identical cancer cells. But the growth pattern is different. Instead of spreading across the lungs, localized mesothelioma is a solid tumor in one location.

The World Health Organization has recently classified these two different types. The “diffuse malignant mesothelioma” is the more common type of mesothelioma. The newly termed “localized malignant mesothelioma” is more rare. Only 0.5% to 1.6% of patients have a localized malignant pleural mesothelioma.

Little is known about localized malignant mesothelioma or about its treatment strategy.

Successful Treatment of Localized Cancer

A new report tells the story of a localized malignant pleural mesothelioma patient who was successfully treated.

The story starts when a 63-year-old man walks into a hospital with a cough. He had been working as an electrical engineer for 45 years with a history of exposure to asbestos. The chest X-ray, CT, and MRI scans all showed a tumor.

A CT-guided biopsy was performed. And immunohistochemistry of the biopsy and antibody tests confirmed mesothelioma. The patient was diagnosed with a localized malignant pleural mesothelioma.

He started with four cycles of chemotherapy with cisplatin and pemetrexed on day 1 every 3 weeks. A post-chemotherapy CT scan showed a good reduction in the size of the tumor. The chemotherapy was working and showed significant tumor shrinkage.

The patient also received surgery. Four weeks after the chemotherapy, the patient underwent surgery via a median sternotomy. This surgery is considered the standard of care. He was able to leave the hospital 15 days after surgery without any complications.

The patient has now been disease-free for 12 months.

Localized malignant mesothelioma is related to asbestos exposure. The rate of malignant mesothelioma is increasing worldwide because of a history of asbestos use. This history suggests that localized malignant mesothelioma may increase in the future.

Chemotherapy followed by surgery could be a standard treatment for localized malignant mesothelioma.

Source:

Maki, Yuho, Yosuke Kiriyama, Tsuyoshi Ueno, Hiroshi Suehisa, Hisayuki Shigematsu, Kazuhiko Saeki, Daijiro Harada, Toshiyuki Kozuki, Norihiro Teramoto, and Motohiro Yamashita. “A Case of Mediastinal Localized Malignant Pleural Mesothelioma Successfully Treated by Chemotherapy and Conversion Surgery.” Acta Medica Okayama 76, no. 3 (2022): 343-347. https://ousar.lib.okayama-u.ac.jp/en/63746

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…